Search research articles
Contact Us
Filters
Showing results (111-120 of 176) with videos related to
Page
of 18
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 2, 2010
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors
Elizabeth Fox, John M Maris, Susan L Cohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group
Shana Jacobs, Elizabeth Fox, Mark Krailo, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 12, 2008
The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial
Sarah Tabbutt, Susan C Nicolson, Peter C Adamson, et al.
Cancer
|
June 4, 2014
The Children's Oncology Group Childhood Cancer Research Network (CCRN): case catchment in the United States
Jessica R B Musselman, Logan G Spector, Mark D Krailo, et al.
Blood
|
October 26, 2007
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma
Elizabeth Fox, Bassem I Razzouk, Brigitte C Widemann, et al.
Neuro-Oncology
|
August 4, 2021
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report
Jack M Su, Lindsay B Kilburn, David B Mansur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study
Terzah M Horton, Debananda Pati, Sharon E Plon, et al.
Neuro-Oncology
|
August 22, 2008
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study
Kristin A Bradley, Ian F Pollack, Joel M Reid, et al.
European Journal of Clinical Pharmacology
|
October 3, 2009
Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months
John T Mondick, Brendan M Johnson, Lynda J Haberer, et al.
Cancer Chemotherapy and Pharmacology
|
October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)
Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 176) with videos related to
Sort By:
Page
of 18
Cancer Chemotherapy and Pharmacology
|
January 2, 2010
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors
Elizabeth Fox, John M Maris, Susan L Cohn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 14, 2010
Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group
Shana Jacobs, Elizabeth Fox, Mark Krailo, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
August 12, 2008
The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial
Sarah Tabbutt, Susan C Nicolson, Peter C Adamson, et al.
Cancer
|
June 4, 2014
The Children's Oncology Group Childhood Cancer Research Network (CCRN): case catchment in the United States
Jessica R B Musselman, Logan G Spector, Mark D Krailo, et al.
Blood
|
October 26, 2007
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma
Elizabeth Fox, Bassem I Razzouk, Brigitte C Widemann, et al.
Neuro-Oncology
|
August 4, 2021
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report
Jack M Su, Lindsay B Kilburn, David B Mansur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study
Terzah M Horton, Debananda Pati, Sharon E Plon, et al.
Neuro-Oncology
|
August 22, 2008
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study
Kristin A Bradley, Ian F Pollack, Joel M Reid, et al.
European Journal of Clinical Pharmacology
|
October 3, 2009
Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months
John T Mondick, Brendan M Johnson, Lynda J Haberer, et al.
Cancer Chemotherapy and Pharmacology
|
October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)
Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
Page
of 18